Loading
Latest filing published 28 Jan 2016 for PDL BIOPHARMA, INC.. Read the official filing
No signal scores available.
Only one filing by Danny J. Hart Jr. is known so far (28 January 2016): a share grant, in PDL Biopharma, Inc. That is too little to draw conclusions. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration